| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/12/2006 | CA2628005A1 Oral antimicrobial pharmaceutical compositions |
| 01/12/2006 | CA2572985A1 Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids |
| 01/12/2006 | CA2572872A1 Tissue factor production inhibitor |
| 01/12/2006 | CA2572639A1 Compressed chewing gum tablet |
| 01/12/2006 | CA2572603A1 Spinal disc nucleus pulposus implant |
| 01/12/2006 | CA2572549A1 Preparation of pharmaceutical compositions containing nanoparticles |
| 01/12/2006 | CA2572491A1 Oral dosage form safeguarded against abuse |
| 01/12/2006 | CA2572363A1 Biomaterial |
| 01/12/2006 | CA2572352A1 Oral dosage form safeguarded against abuse containing (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol |
| 01/12/2006 | CA2571583A1 Sustained-release composition, process for producing the same and use of the same |
| 01/12/2006 | CA2571519A1 Aerosol suspension formulations containing tg 227 ea or tg 134 a as a propellant |
| 01/12/2006 | CA2569712A1 Isocyanate-based compositions and their use |
| 01/12/2006 | CA2569321A1 Rapidly dispersible, fine-grained, separation-resistant pulverulent film coating agent, based on polyvinyl alcohol-polyether graft copolymers and characterised by a particular physical stability and a low degree of roughness |
| 01/12/2006 | CA2568834A1 Medicaments for inhalation comprising steroids and an anticholinergic |
| 01/12/2006 | CA2568262A1 Hydroalcoholic depigmentation gel comprising mequinol and adapalene |
| 01/12/2006 | CA2549505A1 Oleaginous pharmaceutical and cosmetic foam |
| 01/11/2006 | EP1614974A1 Humidity augmenting apparatus |
| 01/11/2006 | EP1614694A1 Titanium dioxide complex having molecule distinguishability |
| 01/11/2006 | EP1614431A2 Compositions for treatment of disorders of the oesophagus |
| 01/11/2006 | EP1614427A1 Inactivated vibrio cholerae vaccine in tablet form |
| 01/11/2006 | EP1614421A2 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine |
| 01/11/2006 | EP1614417A1 Solid preparation for oral use |
| 01/11/2006 | EP1614414A2 Compositions comprising a copper compound for treatment of mammalian diseases |
| 01/11/2006 | EP1614413A2 Solid dosage form for acid-labile active ingredient |
| 01/11/2006 | EP1614412A1 Process for the manufacture of free-flowing, powdery atorvastatin adsorbates |
| 01/11/2006 | EP1613749A2 Ligand-coupled initiator polymers and methods of use |
| 01/11/2006 | EP1613611A1 Novel sesquiterpene oxides as perfuming and flavouring agents |
| 01/11/2006 | EP1613584A1 Highly pure bases of 3,3-diphenyl propylamine monoesters |
| 01/11/2006 | EP1613423A1 Encapsulation system |
| 01/11/2006 | EP1613396A1 Acoustic telemetry apparatus for intrabody communications |
| 01/11/2006 | EP1613389A1 Osmotic pump with means for dissipating internal pressure |
| 01/11/2006 | EP1613374A1 System and method for monitoring power source longevity of an implantable medical device |
| 01/11/2006 | EP1613369A2 Compositions and methods for delivering thymosin beta 4, analogues, isoforms and other derivatives |
| 01/11/2006 | EP1613356A1 A fluoroquinolone aqueous formulation of a ph between 4 and 7 comprising i.a. cyclodextrin, hydroxy acid |
| 01/11/2006 | EP1613355A1 Uptake of macromolecules |
| 01/11/2006 | EP1613353A1 Pharmaceutical compositions for hepatitis c viral protease inhibitors |
| 01/11/2006 | EP1613347A2 Humanized antibodies that recognize beta amyloid peptide |
| 01/11/2006 | EP1613346A2 Microfluidized oil-in-water emulsions and vaccine compositions |
| 01/11/2006 | EP1613334A2 Alcohol-free transdermal insulin composition and processes for manufacture and use thereof |
| 01/11/2006 | EP1613333A1 Oral extended release compressed tablets of multiparticulates |
| 01/11/2006 | EP1613323A1 Pharmaceutical compositions comprising apomorhine for pulmonary inhalation |
| 01/11/2006 | EP1613314A1 Pharmaceutical composition comprising an immunosuppressant for use in the treatment of skin diseases |
| 01/11/2006 | EP1613300A2 Photostabilized topical formulations of ketoprofen containing two uv filters |
| 01/11/2006 | EP1613299A2 Combination product for controlling insect pests |
| 01/11/2006 | EP1613297A1 Therapeutic patch with polysiloxane matrix comprising capsaicin |
| 01/11/2006 | EP1613293A1 Extended transdermal contraceptive regimens |
| 01/11/2006 | EP1613289A1 Orally disintegrating tablets |
| 01/11/2006 | EP1613288A1 Solid pharmaceutical compositions comprising a s1p receptor agonist and a sugar alcohol |
| 01/11/2006 | EP1613287A1 Venlafaxine compositions comprising pellets with double layer coating |
| 01/11/2006 | EP1613285A2 Lipid particles having asymmetric lipid coating and method of preparing same |
| 01/11/2006 | EP1613284A2 Manufacturing process for liposomal preparations |
| 01/11/2006 | EP1613283A1 Composition, method and pharmaceutical preparation for pharmaceutical spray suspensions |
| 01/11/2006 | EP1613282A1 Formulations and methods for treating rhinosinusitis |
| 01/11/2006 | EP1613281A1 Nasal pharmaceutical formulations and methods of using the same |
| 01/11/2006 | EP1613280A1 Nasal pharmaceutical formulations and methods of using the same |
| 01/11/2006 | EP1613279A1 Oral administration form for veterinary use |
| 01/11/2006 | EP1613276A1 Low viscosity liquid dosage forms |
| 01/11/2006 | EP1613270A2 Film forming polymers, methods of use, and devices and applications thereof |
| 01/11/2006 | EP1613254A2 Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof |
| 01/11/2006 | EP1613250A1 Prosthetic foot with tunable performance and improved vertical load/shock absorption |
| 01/11/2006 | EP1560498A4 Chewing gum compositions with encapsulated stain removing agent |
| 01/11/2006 | EP1469887A4 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 01/11/2006 | EP1469743A4 Stable hygroscopic compositions and methods for stabilizing hygroscopic ingredients |
| 01/11/2006 | EP1399130A4 Emulsion and dispersion formulations and method |
| 01/11/2006 | EP1385489B1 Coated granules based on angiotensin-converting enzyme inhibitor |
| 01/11/2006 | EP1198322B1 Apparatus and methods for alternating laser treatment of pharmaceutical dispensers |
| 01/11/2006 | EP1198225B1 Epothilone compositions |
| 01/11/2006 | EP1183302B1 Controlled release polyacrylic acid granules and a process for preparing the same |
| 01/11/2006 | EP1142573B1 Pharmaceutical compositions comprising faropenem sodium and a diamineacetate compound for improving gastrointestinal absorption |
| 01/11/2006 | EP1100479B1 Medicinal products with retarded pharmacological activity and method for the production thereof |
| 01/11/2006 | EP1047422B1 Use of histamine for elevating blood histamine levels |
| 01/11/2006 | EP0941064B1 PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED RELEASE OF beta -LACTAM ANTIBIOTICS |
| 01/11/2006 | EP0831912B1 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 01/11/2006 | EP0827412B1 A method for radiolabeling a somatostatin-derived peptide analogue having one disulfide bond with a radioisotope of rhenium, and their therapeutical applications |
| 01/11/2006 | EP0822822A4 Controlled release of miotic and mydriatic drugs in the anterior chamber |
| 01/11/2006 | CN2750811Y Stype for radical treatment of nasal polyp |
| 01/11/2006 | CN1720257A Methods of down regulating target gene expression in vivo by introduction of interfering RNA |
| 01/11/2006 | CN1720078A Methods and systems for providing orthogonally redundant monitoring in a sedation and analgesia system |
| 01/11/2006 | CN1720065A Dispersible pharmaceutical compositions |
| 01/11/2006 | CN1720064A Pharmaceutical compositions of cell lysate and processes for the production and use thereof |
| 01/11/2006 | CN1720057A Chinese patent medicine for treating baldness and preparing process thereof |
| 01/11/2006 | CN1720048A Method and compositions for treating anxiety |
| 01/11/2006 | CN1720041A Iontophoretic delivery of rotigotine for the treatment of parkinson's disease |
| 01/11/2006 | CN1720036A Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
| 01/11/2006 | CN1720034A Methods of inducing terminal differentiation |
| 01/11/2006 | CN1720033A Water-soluble composition containing coenzyme q10 |
| 01/11/2006 | CN1720031A Propofol-containing fat emulsions |
| 01/11/2006 | CN1720028A Transdermal analgesic systems with reduced abuse potential |
| 01/11/2006 | CN1720027A Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base |
| 01/11/2006 | CN1720026A Sustained release compositions containing alfuzosin |
| 01/11/2006 | CN1720025A Gabapentin tablets and methods for their preparation |
| 01/11/2006 | CN1720024A Therapeutic compositions for drug delivery to and through covering epithelia |
| 01/11/2006 | CN1720023A Quaternary compounds comprising propolis as the active substance |
| 01/11/2006 | CN1718578A Lerivisiticum extract, its preparation method and medicine containing said extract |
| 01/11/2006 | CN1718255A Combined medicinal shoes for treating lower limb nerve affection of diabetic |
| 01/11/2006 | CN1718244A Activated carbon external application antiphlogistine, and its prepn. method |
| 01/11/2006 | CN1718239A Oral adhering piece for treating oral exulceratio, and its prepn. method |
| 01/11/2006 | CN1718237A Traditional Chinese medicine composition for treating colpitis and cervicitis, prepn. method and quality standard therefor |
| 01/11/2006 | CN1718235A Oral liquor preparation contg. radix bupleuri, and its prepn. method |
| 01/11/2006 | CN1718233A Capsule for treating diabetes, and its prepn. process |